Concepedia

Devyani Deshpande

DD

Statistics

Publications

46

Citations

1.9K

H-Index

27

Active since

2010

Affiliations

Baylor University Medical Center(Current)

University of Cape Town

Johns Hopkins University

Johns Hopkins Medicine

The University of Texas Health Science Center at Tyler

Devyani Deshpande is an author at Baylor University Medical Center specializing in pharmacology, pharmacokinetics of antimicrobials, and medicine.

ORCID

Publications per year

2010–2023

46

Publications

46

The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance

Aurelia Schmalstieg, Shashikant Srivastava, Serkan Belkaya et al. · Antimicrobial Agents and Chemotherapy · 2012 · 198 citations · Full text

, , +17

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

Soumya Swaminathan, Jotam G. Pasipanodya, Geetha Ramachandran et al. · Clinical Infectious Diseases · 2016 · 123 citations · Full text

, , +17

Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis

Shashikant Srivastava, Gesham Magombedze, Thearith Koeuth et al. · Antimicrobial Agents and Chemotherapy · 2017 · 113 citations · Full text

, , +17

Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis

Devyani Deshpande, Jotam G. Pasipanodya, Stellah Mpagama et al. · Clinical Infectious Diseases · 2018 · 100 citations · Full text

, , +17

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

Beatriz E. Ferro, Shashikant Srivastava, Devyani Deshpande et al. · Antimicrobial Agents and Chemotherapy · 2016 · 80 citations · Full text

, , +14

1–5 of 46